NO20064190L - Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det samme - Google Patents
Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det sammeInfo
- Publication number
- NO20064190L NO20064190L NO20064190A NO20064190A NO20064190L NO 20064190 L NO20064190 L NO 20064190L NO 20064190 A NO20064190 A NO 20064190A NO 20064190 A NO20064190 A NO 20064190A NO 20064190 L NO20064190 L NO 20064190L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- oral administration
- tamsulosin hydrochloride
- controlled release
- release formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
- B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
- B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
- B41J2/01—Ink jet
- B41J2/17—Ink jet characterised by ink handling
- B41J2/175—Ink supply systems ; Circuit parts therefor
- B41J2/17503—Ink cartridges
- B41J2/17506—Refilling of the cartridge
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
- B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
- B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
- B41J2/01—Ink jet
- B41J2/17—Ink jet characterised by ink handling
- B41J2/175—Ink supply systems ; Circuit parts therefor
- B41J2/17503—Ink cartridges
- B41J2/17553—Outer structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
- B41J2/00—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
- B41J2/005—Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
- B41J2/01—Ink jet
- B41J2/17—Ink jet characterised by ink handling
- B41J2/175—Ink supply systems ; Circuit parts therefor
- B41J2/17503—Ink cartridges
- B41J2/17556—Means for regulating the pressure in the cartridge
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Et preparat for oral administrering av tamsulosinhydroklorid og granul med kontrollert frigivelsesformulering omfattende det samme, fremviser utmerket stabilitet og vedvarende frigivelseskarakteristika av tamsulosin-hydroklorid uavhengig av pH-endringer i en utvidet tidsperiode.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040010384A KR100582350B1 (ko) | 2004-02-17 | 2004-02-17 | 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제 |
PCT/KR2005/000422 WO2005077420A1 (en) | 2004-02-17 | 2005-02-16 | Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20064190L true NO20064190L (no) | 2006-09-15 |
NO341321B1 NO341321B1 (no) | 2017-10-09 |
Family
ID=34858727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20064190A NO341321B1 (no) | 2004-02-17 | 2006-09-15 | Preparat for oral administrering av tamsulosin-hydroklorid og granul med kontrollert frigivelsesformulering omfattende det samme |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070196500A1 (no) |
EP (1) | EP1722821B1 (no) |
JP (1) | JP2007522258A (no) |
KR (1) | KR100582350B1 (no) |
CN (1) | CN1921888B (no) |
AU (1) | AU2005212130B2 (no) |
BR (1) | BRPI0507735A (no) |
CA (1) | CA2556514C (no) |
ES (1) | ES2561940T3 (no) |
IL (1) | IL177402A (no) |
NO (1) | NO341321B1 (no) |
NZ (1) | NZ549135A (no) |
RU (1) | RU2006133313A (no) |
WO (1) | WO2005077420A1 (no) |
ZA (1) | ZA200607730B (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005013960A1 (en) * | 2003-08-12 | 2005-02-17 | Kyungdong Pharm. Co., Ltd. | Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
JP2005104914A (ja) * | 2003-09-30 | 2005-04-21 | Kyowa Yakuhin Kogyo Kk | 塩基性薬剤含有製剤 |
EP2329823A4 (en) | 2008-09-03 | 2013-04-03 | Takeda Pharmaceutical | METHOD FOR IMPROVING CAPACITY OF PREPARATION TO BE ABSORBED AND PREPARATION WHICH CAPACITY TO BE ABSORBED IS IMPROVED |
WO2010040686A1 (de) * | 2008-10-07 | 2010-04-15 | Basf Se | Verfahren zur herstellung oraler darreichungsformen mit kontrollierter freisetzung |
EP2564837B1 (en) | 2010-04-30 | 2019-01-30 | Takeda Pharmaceutical Company Limited | Enteric tablet |
MY162392A (en) | 2010-04-30 | 2017-06-15 | Takeda Pharmaceuticals Co | Enteric tablet |
CN101904829B (zh) * | 2010-07-26 | 2012-02-15 | 安徽省药物研究所 | 药物渗透泵制剂 |
KR102027912B1 (ko) | 2011-02-15 | 2019-10-02 | 지엘팜텍주식회사 | 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제 |
KR20160100570A (ko) * | 2015-02-16 | 2016-08-24 | 한미약품 주식회사 | 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제 |
JP2019524683A (ja) * | 2016-07-15 | 2019-09-05 | ハンミ ファーマシューティカルズ カンパニー リミテッド | 含量均一性が改善されたタムスロシン塩酸塩含有徐放性ペレットを含む経口用薬剤学的製剤 |
KR102391496B1 (ko) | 2016-08-12 | 2022-04-28 | 한미약품 주식회사 | 탐수로신 염산염 함유 서방성 펠렛을 포함하는 용출률이 제어된 경구투여용 약제학적 제제 |
KR102246658B1 (ko) | 2017-06-21 | 2021-04-30 | 한미약품 주식회사 | 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제 |
KR102389339B1 (ko) | 2018-12-26 | 2022-04-22 | (주)휴온스 | 방출 제어되는 고함량 탐스로신 정제 조성물 및 이의 제조방법 |
CN110420179A (zh) * | 2019-08-12 | 2019-11-08 | 韩育娟 | 一种炎琥宁干混悬剂及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
US20030059471A1 (en) * | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
DE10015479A1 (de) * | 2000-03-29 | 2001-10-11 | Basf Ag | Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität |
AU5066101A (en) * | 2000-04-13 | 2001-10-30 | Synthon B.V. | Modified release formulations containing a hypnotic agent |
RU2245136C2 (ru) * | 2001-07-27 | 2005-01-27 | Яманоути Фармасьютикал Ко., ЛТД | Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения |
US20060147531A1 (en) * | 2003-07-01 | 2006-07-06 | Mojca Segula | Tamsulosin core with a coating of polyvinylpyrrolidone and polyfinylacetate |
KR100436701B1 (ko) * | 2003-11-07 | 2004-06-22 | 주식회사 씨티씨바이오 | 염산 탐스로신 함유 방출 조절형 제제 및 그의 제조방법 |
-
2004
- 2004-02-17 KR KR1020040010384A patent/KR100582350B1/ko active IP Right Grant
-
2005
- 2005-02-16 NZ NZ549135A patent/NZ549135A/en not_active IP Right Cessation
- 2005-02-16 EP EP05721856.2A patent/EP1722821B1/en not_active Not-in-force
- 2005-02-16 ES ES05721856.2T patent/ES2561940T3/es active Active
- 2005-02-16 CA CA002556514A patent/CA2556514C/en not_active Expired - Fee Related
- 2005-02-16 RU RU2006133313/15A patent/RU2006133313A/ru unknown
- 2005-02-16 BR BRPI0507735-4A patent/BRPI0507735A/pt not_active Application Discontinuation
- 2005-02-16 JP JP2006554022A patent/JP2007522258A/ja active Pending
- 2005-02-16 CN CN2005800051939A patent/CN1921888B/zh active Active
- 2005-02-16 US US10/597,947 patent/US20070196500A1/en not_active Abandoned
- 2005-02-16 AU AU2005212130A patent/AU2005212130B2/en not_active Ceased
- 2005-02-16 WO PCT/KR2005/000422 patent/WO2005077420A1/en active Application Filing
-
2006
- 2006-08-10 IL IL177402A patent/IL177402A/en not_active IP Right Cessation
- 2006-09-15 ZA ZA200607730A patent/ZA200607730B/en unknown
- 2006-09-15 NO NO20064190A patent/NO341321B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2005077420A1 (en) | 2005-08-25 |
EP1722821A4 (en) | 2012-08-15 |
KR20050082038A (ko) | 2005-08-22 |
AU2005212130B2 (en) | 2007-10-11 |
KR100582350B1 (ko) | 2006-05-22 |
US20070196500A1 (en) | 2007-08-23 |
CA2556514C (en) | 2008-10-28 |
IL177402A0 (en) | 2006-12-10 |
ES2561940T3 (es) | 2016-03-01 |
BRPI0507735A (pt) | 2007-07-10 |
CA2556514A1 (en) | 2005-08-25 |
AU2005212130A1 (en) | 2005-08-25 |
NZ549135A (en) | 2009-10-30 |
CN1921888B (zh) | 2012-02-29 |
NO341321B1 (no) | 2017-10-09 |
ZA200607730B (en) | 2008-05-28 |
JP2007522258A (ja) | 2007-08-09 |
EP1722821A1 (en) | 2006-11-22 |
EP1722821B1 (en) | 2016-01-13 |
IL177402A (en) | 2012-05-31 |
RU2006133313A (ru) | 2008-03-27 |
CN1921888A (zh) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20064190L (no) | Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det samme | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
WO2007048064A3 (en) | Amino-pyrimidines as casein kinase ii (ck2) modulators | |
NO20080164L (no) | N-(pyridin-2-yl)-sulfonamidderivater | |
IS7552A (is) | Bensótengdar heteróarýl amíð afleiður af þíenópýridíni, gagnlegar sem meðferðarmiðlar, lyfjasamsetningar sem innihalda þær og aðferðir við notkun þeirra | |
RS53895B1 (en) | ATP-BINDING CASSETTE TRANSPORT MODULATORS | |
RS53845B1 (en) | OXADIAZOL DERIVATIVES AND THEIR USE AS A POTENTIAL OF METABOTROPIC GLUTAMATE RECEPTORS-842 | |
NO20054006D0 (no) | Cykliske ureaderivater, fremstillingsfremgangsmate derav og farmasoytisk anvendelse av samme som kinaseinhibitorer | |
DK1701946T3 (da) | 1-piperazin- og 1-homopiperazincarboxylatderivater, deres fremstilling og deres terapeutiske anvendelse som inhibitorer af FAAH-enzymet | |
CY2013023I2 (el) | Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεοσως το ενεργο συστατικο | |
NO20053245D0 (no) | Tabletter med modifisert frigjoring av bupropionhydroklorid. | |
IS7192A (is) | Munntökuform af própívíríni, þannig útbúið að hinum virka þætti efnisins er sleppt á löngum tíma | |
IL180488A0 (en) | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof of kinase inhibitors | |
NO20043702L (no) | 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel | |
NO20054244D0 (no) | Nitrogeninneholdende heterocykliske derivater og legemidler inneholdende de samme som den aktive bestanddel | |
RS50534B (sr) | Intranazalna formulacija rotigotina | |
NO20062150L (no) | Nye ketooksadiazolderivater som katepsinhibitorer | |
DK1498411T3 (da) | Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel | |
NO20064934L (no) | Fremgangsmate for fremstilling av et fast, farmasoytisk preparat | |
JP2007506758A5 (ja) | 4−(1−ベンゾフラン−3−イル−メチリデンアミノオキシ−プロポキシ)−安息香酸誘導体および線溶系の障害、血栓症の治療用のpai−1阻害剤としての関連化合物 | |
SE0401342D0 (sv) | Therapeutic compounds | |
NO20073629L (no) | Terapeutiske formuleringer av keratinocyttvekstfaktor | |
DK1753725T3 (da) | Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf. | |
DK1912644T3 (da) | N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid-derivater, fremstilling deraf og terapeutisk anvendelse deraf | |
ATE308522T1 (de) | Opioidrezeptorantagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |